Skip to main content
. 2016 Feb 5;71(Suppl 1):S62–S71. doi: 10.1093/gerona/glv055

Table 2.

Characteristics of Women ≥80 Years of Age With Preserved Cognitive Functioning Separated Based on Sustained High Preserved Cognitive Function Relative to Comparison Group: Mean (SD) or Percent

Characteristics Preserved Cognitive Function-Sustained High (TICS-m ≥ 39), N = 255 Preserved Cognitive Function-Sustained Low (TICS-m < 39), N = 1,369 p Value*
Current age 83.7 (3.0) 84.9 (3.4) <0.001
Education (Miss = 3)
 High school or less 39 (15.4) 352 (25.8) <0.001
 Post high school 117 (46.1) 688 (50.3)
 Post college graduation 98 (38.6) 327 (23.9)
Ethnicity
 African-American 9 (3.5) 75 (5.5) 0.35
 Hispanic 4 (1.6) 18 (1.3)
 Other 5 (2.0) 46 (3.4)
 Non-Hispanic white 237 (92.9) 1,230 (89.8)
Marriage status (Miss = 2)
 Never/divorced 26 (10.2) 199 (14.6) 0.19
 Widowed 73 (28.7) 375 (27.4)
 Married/relationship 155 (61.0) 794 (58.0)
Family income (Miss = 74)
 <$35K 99 (41.4) 679 (51.8) 0.003
 ≥$35K 140 (58.6) 632 (48.2)
Smoking (Miss = 16)
 Never 136 (53.3) 748 (55.3) 0.31
 Former 103 (40.4) 549 (40.6)
 Current 16 (6.3) 56 (4.1)
Alcohol intake (Miss = 2)
 None 95 (37.2) 626 (45.8) 0.03
 <1/day 130 (51.0) 622 (45.5)
 1+/day 30 (11.8) 119 (8.7)
Self-reported health (Miss = 37)
 Excellent 44 (17.5) 105 (7.9) <0.001
 Very good 109 (43.2) 518 (38.8)
 Good 82 (32.5) 578 (43.3)
 Fair/poor 17 (6.8) 134 (10.0)
BMI (Miss = 17)
 <25kg/m2 77 (30.4) 378 (27.9) 0.72
 25–29kg/m2 90 (35.6) 502 (37.1)
 ≥30kg/m2 86 (34.0) 474 (35.0)
Recreational physical activity, METS/wk (Miss = 1) 12.9 (12.6) 11.8 (13.4) 0.23
Moderate/strenuous activity, min/wk (Miss = 22) 73.6 (114.6) 58.9 (98.4) 0.03
Walking, METS, h/wk (Miss = 22) 4.03 (5.97) 2.83 (4.63) <0.001
WHI-HT assignment
 Placebo 135 (52.9) 681 (49.7) 0.35
 HT 120 (47.1) 688 (50.3)
Prior HT use
 No 190 (74.5) 936 (68.4) 0.05
 Yes 65 (25.5) 433 (31.6)
Antidepressant use
 No 237 (92.9) 1,252 (91.4) 0.43
 Yes 18 (7.1) 117 (8.6)
Antihypertensive use
 No 108 (42.4) 446 (32.6) 0.002
 Yes 147 (57.6) 923 (67.4)
Lipid-lowering drug use
 No 165 (64.7) 790 (57.7) 0.04
 Yes 90 (35.3) 579 (42.3)
Diabetes
 No 36 (14.1) 225 (16.4) 0.35
 Yes 219 (85.9) 1,144 (83.6)
Cardiovascular disease
 No 216 (84.7) 1,041 (76.0) 0.002
 Yes 39 (15.3) 328 (24.0)
SF-36 pain (Miss = 38) 68.7 (25.7) 64.5 (25.8) 0.02
Social support (Miss = 108) 36.9 (8.1) 36.7 (7.7) 0.63
Optimism (Miss = 57) 24.3 (3.3) 23.6 (3.0) <0.001
Emotional wellbeing (Miss = 60) 84.1 (12.1) 81.4 (12.8) 0.003
Happiness (Miss = 28)
All or most of the time 197 (77.6) 948 (70.6) 0.02
Less than most of the time 57 (22.4) 394 (29.4)
Stressful life event score (Miss = 193) 2.38 (2.54) 2.64 (2.72) 0.18
Physical function score (Miss = 90) 69.6 (23.7) 60.6 (25.7) <0.001
GDS score (Miss = 9) 1.23 (1.66) 1.94 (2.30) <0.001
Insomnia Rating Scale (Miss = 10) 5.85 (4.03) 5.83 (4.08) 0.96
Apo-E (imputed) (Miss = 469)
 ε4 carrier 33 (17.6) 213 (22.0) 0.17
 Not ε4 carrier 155 (82.4) 754 (78.0)

Notes: Miss = missing; BMI = body mass index; METS = metabolic equivalent of tasks; WHI = women’s health initiative; HT = hormone therapy; GDS = Geriatric Depression Scale; APOE = apolipoprotein E; ε = epsilon.

*Chi-square test or t-test.